About the Journal of Diabetes Science and Technology format
Journal of Diabetes Science and Technology is a peer-reviewed journal published by SAGE, covering Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Pancreatic function and diabetes.
| Publisher | SAGE |
|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Journal of Diabetes Science and Technology, 12(3), pp. 45–58.
Formats any DOI in Journal of Diabetes Science and Technology style. No sign-up.
|
|---|
| Publishes research in | Diabetes Management and Research Hyperglycemia and glycemic control in critically ill and hospitalized patients Pancreatic function and diabetes Diabetes and associated disorders Diabetes Treatment and Management |
|---|
| ISSN | 1932-2968 |
|---|
| Citation impact (2-yr) | 4.02 |
|---|
| h-index | 123 |
|---|
| i10-index | 2,213 |
|---|
| Total citations | 104,105 |
|---|
| Top institutions publishing here | Mills Peninsula Health Services |
|---|
| Journal website | us.sagepub.com |
|---|
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
|---|
Papers published in Journal of Diabetes Science and Technology per year
Citation impact of Journal of Diabetes Science and Technology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Diabetes Science and Technology
Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed
Suzanne M. de la Monte, Jack R. Wands · 1 Nov 2008
Alzheimer's disease (AD) has characteristic histopathological, molecular, and biochemical abnormalities, including cell loss; abundant neurofibrillary tangles; dystrophic neurites; amyloid precursor protein, amyloid-beta (APP-Abeta) deposits; increased activation of prodeath genes and signaling pathways; impaired energy metabolism; mitochondrial dysfunction; chronic oxidative stress; and DNA damage. Gaining a better understanding of AD pathogenesis will require a framework that…
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Bruce W. Bode, Valerie Garrett, Jordan Messler et al. · 9 May 2020
Introduction: Diabetes has emerged as an important risk factor for severe illness and death from COVID-19. There is a paucity of information on glycemic control among hospitalized COVID-19 patients with diabetes and acute hyperglycemia. Methods: This retrospective observational study of laboratory-confirmed COVID-19 adults evaluated glycemic and clinical outcomes in patients with and without diabetes and/or…
The UVA/PADOVA Type 1 Diabetes Simulator
Chiara Dalla Man, Francesco Micheletto, Dayu Lv et al. · 1 Jan 2014
Recent studies have provided new insights into nonlinearities of insulin action in the hypoglycemic range and into glucagon kinetics as it relates to response to hypoglycemia. Based on these data, we developed a new version of the UVA/PADOVA Type 1 Diabetes Simulator, which was submitted to FDA in 2013 (S2013). The model of glucose kinetics…
Blood Lactate Measurements and Analysis during Exercise: A Guide for Clinicians
Matthew L. Goodwin, James E. Harris, Andrés Hernández et al. · 1 Jul 2007
Blood lactate concentration ([La(-)](b)) is one of the most often measured parameters during clinical exercise testing as well as during performance testing of athletes. While an elevated [La(-)](b) may be indicative of ischemia or hypoxemia, it may also be a "normal" physiological response to exertion. In response to "all-out" maximal exertion lasting 30-120 seconds, peak…
The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c
Roy W. Beck, Richard M. Bergenstal, Peiyao Cheng et al. · 13 Jan 2019
Background: As the use of continuous glucose monitoring (CGM) increases, there is a need to better understand key metrics of time in range 70-180 mg/dL (TIR 70-180 ) and hyperglycemia and how they relate to hemoglobin A1c (A1C). Methods: Analyses were conducted utilizing datasets from four randomized trials encompassing 545 adults with type 1 diabetes…
